Product ID:ALBEMET 120
MSDS Date:10/01/1996
FSC:6810
NIIN:00N092270
Status Code:A
MSDS Number: CJRQW

BRUSH WELLMAN INC

14710 W PORTAGE RIVER S RD
ELMORE, OH 43416-9502
US

Emergency Phone: 800-424-9300 (CHEMTREC)

Info Phone: 800-862-4118

Preparer: M. KOLANZ / D. C. DEUBNER

Cage: 4B151

BRUSH WELLMAN INC.

ELMORE, OH 43416-9502 US

Telephone: 800-862-4118; -4177 (FAX)

Cage: 4B151

BERYLLIUM

CAS: 7440-41-7

RTECS: DS1750000

OSHA PEL see Table Z-2

ACGIH TLV: 0.002 MG/M3

ALUMINUM; (ALUMINUM DUST, ALUMINUM FUMES AND RESP. DUST)

CAS: 7429-90-5

RTECS: BD0330000

Fraction By Weight: BALANCE

OSHA PEL 15 MG/M3

ACGIH TLV: 10 MG/M3

Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:YES IARC:YES OSHA:NO
Health Hazards Acute and Chronic:ACUTE: PROD IS INSOL & DOES NOT CAUSE
ACUTE HLTH EFTS. CHRONIC: INHALING DUST/FUMES CONTAINING BERYLLIUM
MAY CAUSE SERIOUS, CHRONIC LUNG DISEASE CALLED CHRONIC BERYLLIUM
DISEASE (CBD). OVER TIME LUNG DISEASE CAN BE FATAL. SYMPS MAY INCL
COUGH, CHEST PAIN, SHORTNESS OF BRTH, WT LOSS, WEAK, & FATG.
LONG-TERM EFTS MAY INCL LOSS OF LUNG FUNC, FIBROSIS/SUBSEQUENT
SECONDARY EFTS ON HEART W/EVENTUAL PER M IMPAIRMENT. CBD IS A
HYPERSENSITIVITY/ALLERGIC CNDTN IN WHICH TISS OF LUNGS BECOME
INFLAMED W/CELLULAR NODULAR RXN. THIS INFLAMM, SOMETIMES
W/ACCOMPANYING FIBROSIS, MAY RESTRICT EXCHANGE OF OXYGEN B ETWEEN
LUNGS & (EFTS OF OVEREXP)
Explanation of Carcinogenicity:BERYLLIUM: IARC MONOGRAPHS, SUPPLEMENT,
VOLUME 7, PAGE 127, 1998: GROUP 2A. NTP 8TH ANNUAL REPORT ON
CARCINOGENS, 1998: REASONABLY ANTICIPATED TO BE HUMAN CARCINOGEN.
HUMAN: LUNG FIBROSIS.
Effects of Overexposure:HLTH HAZ: BLOODSTREAM. THIS ALLERGIC RESPONSE
TO BERYLLIUM IS LIMITED TO SUSCEPTIBLE PERSONS. MED SCIENCE
SUGGESTS THIS SUSCEPTIBILITY IS RELATED TO GENETIC FACTORS. EXPOS
TO AIRBORNE BERYLLIUM DOES N OT CAUSE CHRONIC REACTION IN MOST
PEOPLE. PLEASE CONT NEHC FOR MORE COMPLETE INFORMATION .
Medical Cond Aggravated by Exposure:PERS W/IMPAIRED PULM FUNC, AIRWAY
DISEASES/CNDTNS SUCH AS ASTHMA, EMPHYSEMA, CHRONIC BRONCH, ETC, MAY
INCUR FURTHER IMPAIRMENT IF DUST/FUMES ARE INHALED. IF PRIOR
DMG/DISEASE TO NEUROLOGIC (SUP DAT)

First Aid:INHAL: BRTHG DFCLTY CAUSED BY INHAL OF DUST/FUME REQUIRES
IMMED REMOVAL TO FRESH AIR. THERE ARE NO KNOWN CAUSES IN WHICH A
PERS STOPPED BRTHG AS RSLT OF EXPOS. IF BRTHG HAS STOPPED, PERFORM
ARTF RESP & OBTAIN MED HELP. INGEST: SWALLOWING METAL POWDER/DUST
CAN BE TREATED BY HAVING VICTIM DRINK LGE QTYS IF WATER &
ATTEMPTING TO INDUCE VOMIT, IF CONSCIOUS. OBTAIN MED HELP. SKIN:
SKIN CUTS & ABRASIONS SHOULD BE TREATED BY STD FIRST AID. SKIN
CONTAM W/DUST OR POWDER CAN BE REMOVED BY WASHING W/SOAP & WATER.
OBTAIN MED HELP IF IRRIT PERSISTS. ACCIDENTAL IMPLANTATION OF THIS
MATL BENEATH SKIN REQUIRE S IT BE REMOVED TO PVNT (OTHER INFO)

Flash Point:N/A TO SOLIDS
Lower Limits:N/A TO SOLID
Upper Limits:N/A TO SOLID
Extinguishing Media:TO EXTING METAL POWDER FIRE, USE CLASS D FIRE
EXTING POWDER. DO NOT USE WATER TO EXTING FIRES AROUND OPERATIONS
INVOLVING MOLTEN METAL DUE TO POTENTIAL FOR STEAM EXPLOSIONS.
Fire Fighting Procedures:WEAR NIOSH APPRVD SCBA & FULL PROT EQUIP .
EXPLO HAZ: MOLTEN ALUMINUM IN CONT W/WATER MAY REACT W/EXPLO FORCE.
IF CONVERTED TO POWDER, TESTS ON POWDER AT CONCS 1000-3000 G/M3
ACCORDING TO ASTM S TD E 1226 "STD TEST METH FOR PRESS FOR COMBUST
DUSTS" FOUND DUST TO BE EXPLO DUST HAZ, CATEGORY ST-1 "WEAKLY
EXPLO".
Unusual Fire/Explosion Hazard:INGOTS/SOLIDS MAY CONTAIN SHRINKAGE
CAVITIES WHICH PERMIT ENTRAPMENT OF WATER. TO ELIMINATE MOISTURE
PRIOR TO USE IN ANY MELTING OPERATION & TO SAFEGUARD AGAINST POSS
STEAM EXPLO HAZS, INGOTS SHOULD B E THORO DRY BEFORE CHARGING INTO
FURNACE. PREHEATING OF INGOTS IS DESIRABLE PRIOR TO MELTING. (FIRE
FIGHT PROCS)

Spill Release Procedures:IN SOLID FORM, MATL POSES NO SPECIAL
HLTH/ENVIRON RISK. IF MATL IS IN POWDER/DUST FORM, ESTABLISH
RESTRICTED ENTRY ZONE BASED ON SEV OF SPILL. PERS ENTERING
RESTRICTED ZONE MUST WEAR ADEQ NIOSH APPRVD RESP PROT & PROT CLTHG
APPROP FOR SEV OF SPILL. CLEANUP SHOULD BE CONDUCTED W/VACUUM SYS
UTILIZING HIGH EFFICIENCY PARTICULATE AIR (HEPA) FILTRATION SYS
FOLLOWED BY WET CLEANING METHS. (SARA REGS)
Neutralizing Agent:WASTE DISP METH: STATE & LOC REQS. THIS MATL IS NOT
CLASSIFIED A HAZ WASTE UNDER FED LAW.

Handling and Storage Precautions:WEAR GLOVES WHEN HNDLG PARTS W/SHARP
EDGES. STORE IN DRY AREA. EXPOS TO AIRBORNE MATLS SHOULD BE
DETERMINED BY HAVING AIR SAMPLES TAKEN IN EMPLOYEE BRTHG ZONE, WORK
AREA, & DEPARTMENT. FREQUENCY & TYP E OF AIR SAMPLING SHOULD BE AS
SPECIFIED BY INDUS HYGIENIST/OTHER QUALIFIED PROFESSIONAL.
Other Precautions:AIR SAMPLE RSLTS SHOULD BE MADE AVAIL TO EMPLOYEES.
PERS EXPOSED TO AIRBORNE CONCS OF THIS MATL SHOULD BE INCLUDED IN
PERIODIC MED SURVEILLANCE PROGRAM. PROGRAM SHOULD INCL EXAMINATION
OF SKIN & RESP SYS. NON-SPECIFIC FINDINGS OF SKIN RASH, SKIN
GRANULOMA/RESP SIGNS/SYMPS MAY INDICATE RXN TO THIS MA TL. (FED
REGS)

Respiratory Protection:WHEN POTENTIAL EXPOSURES ARE ABOVE OCCUPATIONAL
LIMITS, NIOSH APPROVED RESPIRATORS MUST BE USED AS SPECIFIED BY
INDUSTRIAL HYGIENIST/OTHER QUALIFIED PROFESSIONAL. RESPIRATOR USERS
MUST BE MEDICALLY EV ALUATED TO DETERMINE IF THEY ARE PHYSICALLY
CAPABLE OF WEARING THE RESPIRATOR. PLEASE CONTACT NEHC FOR MORE
INFORMATION .
Ventilation:WHENEVER POSS, USE OF LOC EXHST VENT/OTHER ENGINEERING CTLS
IS PREF METH OF CONTROLLING EXPOS TO AIRBORNE DUST & FUME. CONT
NEHC FOR MORE INFO .
Protective Gloves:WEAR IMPERVIOUS GLOVES .
Eye Protection:ANSI APPROVED CHEMICAL WORKERS GOGGLES .
Other Protective Equipment:EYEWASH & DELUGE SHWR MTG ANSI DESIGN CRITER
. NO SPECIAL PROT EQUIP/CLTHG REQUIRED FOR SOLID FORMS. WEAR PROT
CLTHG TO PROTECT FROM ACCIDENTAL MOLTEN METAL SPLASH. CONT NEHC FOR
MORE INFO .
Work Hygienic Practices:VACUUM & WET CLEANING METHS ARE REC FOR DUST
REMOVAL. BE CERTAIN TO DE-ENERGIZE ELEC SYS, AS NEC, BEFORE
BEGINNING WET CLEANING. VACUUM CLEANERS W/HIGH EFFICIENCY
PARTICULATE AIR (HEPA) (STATE REGS)
Supplemental Safety and Health
MED CNDTNS: (NERV), CIRCULATORY, HEMATOLOGIC (BLOOD)/URINARY (KIDNEY)
SYS HAS OCCURRED, PROPER SCREENING/EXAMINATIONS SHOULD BE CONDUCTED
ON INDIVIDUALS WHO MAY BE EXPOSED TO FURTHER RISK WHERE HNDLG &
USE OF THIS MATL MAY CAUSE EXPOS.

Solubility in Water:NONE
Appearance and Odor:GRAY SOLID; NO ODOR.
Percent Volatiles by Volume:NONE

Stability Indicator/Materials to Avoid:YES
REACTS WITH SOME ACIDS AND CAUSTICS SOLUTIONS TO PRODUCE HYDROGEN GAS.
HYDROGEN GAS CAN BE AN EXPLOSION HAZARD. POWDERED ALUMINUM AND
CHLORINATED HYDROCARBONS MAY REACT WITH EXPLOSIVE FORCE.
Hazardous Decomposition Products:NONE UNDER NORMAL CONDITIONS OF USE.

Waste Disposal Methods:WHEN RECYCLED (USED IN PROCESS TO RECOVER
METALS), MATL IS NOT CLASSIFIED AS HAZ WASTE UNDER FED LAW.
DUSTY/DUST-LIKE MATLS SHOULD BE SEALED INSIDE 2 PLASTIC BAGS,
PLACED IN DOT APPRVD CONTR, & APPROP LABELED. WHEN SPENT PRODS ARE
DECLARED SOLID WASTES (NO LONGER RECYCABLE), THEY MUST BE LABELED,
MA NAGED & DISPOSED OF, I/A/W FED, (NEUT AGENT)

Toxicological Information:FOR QUESTIONS CONCERNING TOX INFO WRITE TO:
MED DIRECTOR, AT ADDRESS ON FIRST PAGE. --OTHER INFO:
EFFECTIVENESS, OTHER IMMUNOSUPPRESSIVE AGENTS, SUCH AS
CYCLOPHOSPHAMIDE, CYCLOSPORINE/METHOTREXATE, HA VE BEEN USED. THESE
LATTER AGENTS REMAIN INVESTIGATIONAL. FURTHER, IN VIEW OF POTENTIAL
SIDE EFTS OF ALL IMMUNOSUPPRESSIVE MEDICATIONS, INCL STEROIDS SUCH
AS PREDNISONE, THEY SHOULD BE USED ONLY UNDER DIRECT CARE OF MD.
IN GEN, THESE MEDICATIONS SHOULD BE RESERVED FOR CASES
W/SIGNIFICANT SYMPS &/OR SIGNIFICANT LOSS OF LUNG FUNC. OTHER
SYMPTOMATIC TREATMENT, SUCH AS OXYGEN, INHALED STEROIDS/BRONCHO
DILATORES, MAY BE (ECOLOGICAL INFO)

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.

Ecological:MATL IS INSOL IN WATER. MATL CAN BE RECYCLED; CONT YOUR
SALES REPRESENTATIVE. --TOX INFO: USED BY SOME MD'S & ARE EFFECTIVE
IN SELECTED CASES. DECISION ABOUT WHEN & W/WHAT MEDICATION TO TREAT
IS A JUD GMENT SITUATION FOR INDIVIDUAL MD'S. FOR MOST PART,
TREATMENT IS RESERVED FOR THOSE PERS W/SYMPS & MEASURABLE LOSS OF
LUNG FUNC. VALUE OF STARTING ORAL STEROID TREATMENT, BEFORE
SIGNS/SYMPS ARE EVIDEN T, REMAINS A MEDICALLY UNRESOLVED ISSUE
CURRENTLY UNDER STUDY. SOME MD'S ARE CONCERNED THAT THEIR PATIENTS
MAY DEVELOP A RESIST TO MEDICATION IF IT IS STARTED TOO SOON.
(TRANSPORT INFO)

Transport Information:THERE ARE NO DOT HAZ MATL REGS WHICH APPLY TO
PACKAGING & LABELING OF THIS PROD AS SHIPPED BY MFR. HAZ
COMMUNICATION REGS OF U.S. OCCUP SFTY & HLTH ADMIN REQ MATL BE
LABELED. CONT NEHC FOR MORE INFO ( ). --ECOLOGICAL INFO: EFTS OF
CONTINUED LOW EXPOS TO BERYLLIUM ARE UNKNOWN FOR PERS WHO ARE
SENSITIZED TO BERYLLIUM/WHO HAVE A DIAGNOSIS OF CBD. THIS
UNCERTAINTY LEADS SOME MD'S TO ADVISE REDUCTIO N/ELIM OF FURTHER
EXPOS TO BERYLLIUM. HOWEVER, SOME PERS HAVE DEVELOPED CBD/HAVE
GRADUALLY BECOME WORSE AFTER REMOVAL FROM FURTHER EXPOS. OTHERS
HAVE CONTINUED TO WORK IN BERYLLIUM INDUSTRY W/OUT ANY
ADDNL/ACCELERATED LOSS OF LUNG FUNC.

SARA Title III Information:BERYLLIUM IS REPORTABLE UNDER SECTION 313.
CAS NUMBERS ARE LISTED IN INGS SECTION. YOU MAY OBTAIN ADDNL INFO
BY CALLING EPA SARA TITLE III HOTLINE AT 1-800-535-0202 (OR
202-555-1411). --SPILL PROC: SP ECIAL PREC MUST BE TAKEN WHEN
CHANGING FILTERS ON HEPA VACUUM CLEANERS USED TO CLEAN UP
POTENTIALLY TOX MATLS. CAUTION SHOULD BE TAKEN TO MIN AIRBORNE
GENERATION OF POWDER/DUST & AVOID CONTAM OF AIR & WATER. DEPENDING
UPON QTY OF MATL RELEASED, FINE POWDER/DUST SPILLS TO ENVIRON MAY
REQ REPORTING TO NATL RESPONSE CTR AT (800) 424-8802 AS WELL AS
STATE EMER RESPONSE COMMISSION & LOC EMER PLANNING C OMMITTEE.
Federal Regulatory Information:OSHA HAZ COMMUNICATION STD, 29 CFR
1910.1200: COMPONENTS OF THIS PROD ARE CONSIDERED HAZ INGS.
WASTEWATER REGS CAN VARY CONSIDERABLY. CONT YOUR LOC & STATE GOVTS
TO DETERMINE THEIR REQS. TSCA: THIS MA TL IS A MIXT. COMPONENTS OF
THIS MATL ARE LISTED ON TSCA CHEM SUBSTANCE INVENTORY OF EXISTING
CHEM SUBSTANCES. CONT NEHC FOR MORE INFO . --OTHER PREC: A MIN MED
SURVEILLANCE PROGRAM SHOULD INCL (1) SKIN EXAMINATION, (2) RESP
HISTORY, (3) AUSCULTATION OF LUNGS, (4) SPIROMETRY (FVC & FEV), &
(5) PERIODIC CHEST X-RAY. IN ADDN, SPECIALIZED, SPECIFIC,
IMMUNOLOGICAL BLOOD TEST, BERYLLIUM BLOOD LYMPHOCYTE PROLIFERATION
TEST (STATE REGS)
State Regulatory Information:N/P --FED REGS: (BLPT), IS AVAIL [ON
LIMITED BASIS TO ASSIST IN DIAGNOSIS] TO SCREEN BERYLLIUM-EXPOSED
PERS FOR BERYLLIUM RXNS. NOTE: IT SHOULD BE RECOGNIZED THAT BLPT
HAS LIMITED SENSITIVITY FOR CBD. PERS WHO HAVE ABNORM BLPT ARE
NORM REFERRED TO LUNG SPECIALIST FOR ADDNL SPECIFIC TESTS TO
DETERMINE IF CBD IS PRESENT. CONT NEHC FOR MORE INFO . --HYGIENE
PRACT: FILTERS ARE REC TYPE. USE OF C OMPRESSED AIR/BROOMS TO
REMOVE DUSTS MUST BE AVOIDED AS SUCH ACTICITY CAN RSLT IN UNNEC
SHORT-TERM E LEVATED EXPOS TO AIRBORNE DUSTS. DURING REPAIR/MAINT
POTENTIAL EXISTS FOR EXPOS IN EXCESS OF OCCUP STDS. CONT NEHC FOR
MORE INFO .